| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.26 | 3e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.25 | 9e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.24 | 0.0004 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 0.0006 |